Company Filing History:
Years Active: 2006
Title: **Innovator Spotlight: Chinthalapally V Rao**
Introduction
Chinthalapally V Rao, based in Croton-on-Hudson, NY, is a prominent inventor with a focus on developing innovative treatments for cancer. He has made significant contributions to the field of oncology through his patented work, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Chinthalapally V Rao holds one groundbreaking patent titled "Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers." This patent details agents and methods aimed at the chemoprevention and treatment of neoplasms. It specifically highlights a selective inhibitor of inducible nitric oxide synthase, used individually or in combination with an inhibitor of cyclooxygenase-2. The pharmaceutical composition is targeted toward preventing and treating various cancers, including colorectal cancer, and aims to address the fibrosis associated with radiation therapy and adenomatous polyps, particularly in patients with familial adenomatous polyposis (FAP).
Career Highlights
Chinthalapally V Rao's work primarily takes place at Pharmacia Corporation, where he contributes to cutting-edge research and development in pharmaceuticals. His expertise in cancer treatment and prevention has established him as a key figure in this important field. The impact of his innovations is significant, aiding in the exploration of new therapeutic avenues for patients battling cancer.
Collaborations
Throughout his career, Chinthalapally V Rao has collaborated with notable colleagues, including Pamela T Manning and Jane R Connor. These partnerships exemplify a team-oriented approach to addressing complex medical challenges and highlight the collaborative spirit prevalent in the research community.
Conclusion
Chinthalapally V Rao's dedication to cancer research and innovation is evident through his patent and collaborative efforts at Pharmacia Corporation. His contributions not only advance scientific understanding but also promise to better the lives of those affected by cancer. As the landscape of medical treatment continues to evolve, Rao’s work remains pivotal in the fight against neoplasia.